Table 2 The therapeutic status for patients with lung adenocarcinoma after surgery
From: Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance
Stage | Number | Therapy after surgery | |||
|---|---|---|---|---|---|
No therapy | Chemotherapy | Radiotherapy | |||
1-2 cycles | > 2 cycles | ||||
I | 23 | 20 | 0 | 0 | 3 |
II | 57 | 0 | 12 | 40 | 27 |
III | 26 | 0 | 0 | 26 | 21 |
total | 106 | 20 | 12 | 66 | 51 |